Cash Flow Statement

Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Callan Jmb (CJMB) Capital Expenditures (2024 - 2025)

Callan Jmb's Capital Expenditures history spans 2 years, with the latest figure at $169390.0 for Q3 2025.

On a quarterly basis, Capital Expenditures rose 57712.29% to $169390.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $616896.0, a N/A change, with the full-year FY2024 number at $46167.0, down 90.58% from a year prior.
Capital Expenditures hit $169390.0 in Q3 2025 for Callan Jmb, down from $432506.0 in the prior quarter.
Over the last five years, Capital Expenditures for CJMB hit a ceiling of $432506.0 in Q2 2025 and a floor of $293.0 in Q3 2024.